Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1030 (Showing 61 to 80) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Vegetarianism and chronic disease risk Yumie Takata Oregon State University PLCO Jan 8, 2020 PLCO-564
Infection-based markers of glioma risk in the NCI cohort consortium Stephanie Smith-Warner Harvard TH Chan School of Public Health PLCO Dec 27, 2019 2019-1025
Mutational landscape of in situ breast cancers in relation to invasive breast cancers Clara Bodelon NIH PLCO Dec 27, 2019 2019-1017
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and ovarian and endometrial cancers in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Rena Jones National Cancer Institute PLCO Dec 27, 2019 2019-1010
Associations of Serum Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Colorectal Cancer Risk Doratha Byrd National Cancer Institute PLCO Dec 27, 2019 2019-1004
Graph Convolutional Networks for Cancer Diagnosis, Prognosis and Therapeutic Response Prediction Faisal Mahmood Brigham and Women's Hospital PLCO Dec 18, 2019 PLCOI-562
Instrumental variable methods in survival outcome Youjin Lee University of Pennsylvania PLCO Dec 16, 2019 PLCO-561
Blood metabolomics, smoking and lung cancer risk Wei Jie Seow National University of Singapore PLCO Dec 16, 2019 PLCO-558
Analyses using GWAS data from PLCO to evaluate genetic impact on colorectal screening and outcomes Wen-Yi Huang National Cancer Institute PLCO Dec 11, 2019 PLCO-560
Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Dec 11, 2019 PLCO-559
Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men Burcu Darst University of Southern California PLCO Nov 26, 2019 PLCO-555
Associations of Dietary Inflammatory and Insulinemic Potential with Risk of Cancer Development Fred Tabung The Ohio State University College of Medicine PLCO Nov 25, 2019 PLCO-553
Association of endogenous estrogens, estrogen metabolites, androgens and androgen metabolites with Ovarian Cancer Britton Trabert NIH PLCO Nov 21, 2019 2016-0047
A Comparison Between Multi Classification Algorithms on PLCO Colorectal Cancer Dataset Bawer Berwary Van Yuzuncu Yil University PLCO Nov 14, 2019 PLCO-533
Predicting Cancer diagnosis based on preliminary screenings Jonathan Mendoza Independent PLCO Nov 14, 2019 PLCO-532
Link-based survival additive models with mixed types of censoring. Giampiero Marra University College London PLCO Nov 14, 2019 PLCO-538
Data mining study on clinical and imaging data for assessing cancer risk and estimating outcome Shandong Wu University of Pittsburgh, Department of Radiology PLCO Nov 14, 2019 PLCOI-519
Drinking and pre-diagnosed BMI trajectories and their impact on the mortality of upper-gastrointestinal cancers in the PLCO population. Jianjun Li Sun Yat-Sen University Caner Center PLCO Nov 13, 2019 PLCO-546
Machine Learning Application of Cancer Data Analysis Mochen Li Purdue University PLCO Nov 13, 2019 PLCO-552
Predicting lung cancer recurrence with machine learning Flavio Calmon Harvard University PLCO Nov 13, 2019 PLCOI-522